ABEONA THERAPEUTICS INC. — Director's Dealing 2021

Jun 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-06-01

Reporting Person: Seshadri Vishwas (SVP, Head of Res./Clin. Dev.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-01	Common stock	A	200000	—	Acquired	200000	Direct
2021-06-01	Common stock	A	100000	—	Acquired	300000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Stock Option (right to buy)	$1.71	A	400000	Acquired	2031-06-01	Common Stock (400000)	Direct

Footnotes

F1: The restricted stock will vest 25% on each of June 1, 2022, June 1, 2023, June 1, 2024 and June 1, 2025.

F2: The restricted stock will vest 100% on each of June 1, 2022.

F3: The options will vest 25% on June 1, 2022, and in 36 equal monthly installments thereafter.